Navigation Links
Swedish University Hospital Improves Monitoring of Treatment Efficacy in Multiple Sclerosis With Synthetic MRI Innovation
Date:9/1/2011

STOCKHOLM, September 1, 2011 /PRNewswire/ --

The medical imaging company SyntheticMR AB, a subsidiary to Accelerator Nordic AB, has secured an order for their magnetic resonance imaging software from Umeå University Hospital through their partner Sectra. The software will be used in clinical practice to monitor the treatment efficacy of multiple sclerosis (MS).

The software, SyMRI Diagnostics, includes tools to automatically estimate a measure for brain atrophy and, with minor manual interaction, retrieve the volume of local brain structures and lesions. "SyMRI enables us to retrieve accurate values on the patients status that we could not get before", says Dr Richard Birgander, Neuroradiologist at Umeå University Hospital. "We have analyzed the software's functionality and the results look very good, which has led to a decision to introduce it in regular clinical procedures."

"Magnetic resonance imaging (MRI) generally has been about looking at pictures and trying to interpret them. SyMRI finally provides us with objective numbers," says Dr Anders Svenningsson, Neurologist at Umeå University Hosptial. "My goal is to integrate the SyMRI approach into the Swedish MS register to have more accurate follow-up possibilities for these patients." The Swedish MS register is a nation-wide database that strives to improve care and convey knowledge of Multiple Sclerosis.

The software will be seamlessly integrated in the hospital's radiology IT solutions from Sectra. "Offering third-party clinical innovations like SyMRI Diagnostics tightly integrated in our own IT solutions is an important part of our mission to offer our customers ways to improve their efficiency and the quality of care for their patients," says Dr Torbjörn Kronander, President of Sectra's medical operations.

SyntheticMR has a long standing relationship with Umeå University Hospital, where the SyMRI Diagnostics product has been evaluated on site since 2009 in order to better understand how the software can be used in clinical practice.

Accelerator Nordic AB is a group of Life Science companies focused on pharmaceutical drug development and medical devices. Accelerator's subsidiaries have exposure towards large growth markets such as cancer therapy, medical imaging and orthopedics. The business model is centered on partnering or out-licensing. Accelerator Nordic is publicly traded on the Aktietorget exchange in Stockholm, Sweden. For more information please visit, http://www.acceleratorab.se.

SyntheticMR AB, a subsidiary to Accelerator Nordic AB, has developed SyMRI Diagnostics, software for more effective Magnetic Resonance Imaging. SyMRI Diagnostics uses a rapid MRI scan that provides a measure for patient tissue properties. Using these properties conventional MRI images and tissue images can be generated. In this way examination time is reduced for the patient and the decision support is improved for the radiologist. For more information, please visit http://www.syntheticmr.se.

Sectra develops and sells IT systems and products for radiology, mammography and orthopaedics. More than 1,100 hospitals, clinics and imaging centers worldwide use the systems daily, together performing over 55 million radiology examinations annually. This makes Sectra one of the world- leading companies within systems for handling digital radiology images. In Scandinavia, Sectra is the market leader with more than 50% of all film-free installations. Sectra's systems have been installed in North America, Scandinavia and most major countries in Europe and the Far East. Sectra was founded in 1978 and has its roots in Linköping University in Sweden. The company's business operation includes cutting-edge products and services within the niche segments of medical systems and secure communication systems. Sectra has offices in 12 countries and operates through partners worldwide. Sales in the 2010/2011 fiscal year totaled SEK 911 million. The Sectra share is quoted on the NASDAQ OMX Stockholm AB exchange. For more information, visit http://www.sectra.com.


'/>"/>
SOURCE Accelerator Nordic AB and SyntheticMR AB
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
2. Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research
3. Swedish Neuroscience Institute and Institute for Systems Biology in Seattle Form Alliance to Learn More about Brain Diseases
4. University of Houston receives NSF grant for high school teachers program
5. New nanoscale parameter by Aalto University resolves dilemmas on silicon property
6. University of Muenster Bridges 1st Patient to Transplant with SynCardias Total Artificial Heart
7. Elsevier and the National University of Singapore Announce Winners of 24-Hour Hackathon
8. The Human Brain is Sensitive to Light, Breakthrough Findings From Valkee and the University of Oulu
9. CEM President and CEO Delivers Commencement Address at the University of Texas at Austin Chemistry and Biochemistry Department Graduation
10. Computerized system to prevent SIDS developed by Ben-Gurion University students
11. University of Dayton Study Overturns 250-Year-Old Belief About Effects of Age, Repeated Injury on Tissue Regeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... PathSensors, Inc., ... Advisory Board. Dr. Lamka will assist PathSensors in expanding the use of the ... deploys the CANARY® test platform for the detection of harmful pathogens, including a ...
(Date:4/27/2016)... April 27, 2016 MedDay, a biotechnology ... announces the appointment of Catherine Moukheibir as Chairman of its ... Chairman, Jean Jacques Garaud , who contributed to the ... effective immediately. Catherine started her career in strategy ... and London .  She held C-Suite level ...
(Date:4/26/2016)... CAMBRIDGE, Mass. (PRWEB) , ... April 26, 2016 , ... ... Herr has been selected as one of three finalists for the European Inventor ... the EPO’s annual innovation prize will be announced at a ceremony in Lisbon on ...
(Date:4/26/2016)... ... April 26, 2016 , ... BioFactura, Inc ., a ... round of financing. Healthy investor interest drove significant oversubscription of the original $1.5M ... known as biosimilars, to the advanced preclinical stages. , Chief Executive Officer and President, ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):